Tampere University Hospital is a teaching hospital of Tampere University along Teiskontie at the Kauppi district in Tampere, Finland.

There are 1,000 beds in Dept. of Intensive Care, Tampere University Hospital.

During the past decade, Dept. of Intensive Care, Tampere University Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dept. of Intensive Care, Tampere University Hospital" #1 sponsor was "Anders Perner" with 1 trials, followed by "Dr. Morten Hylander Møller" with 1 trials sponsored, "Herlev Hospital" with 1 trials sponsored, "Orion Corporation, Orion Pharma" with 1 trials sponsored and "University of Helsinki" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dept. of Intensive Care, Tampere University Hospital" #1 collaborator was "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 2 trials as a collaborator, "Rigshospitalet, Denmark" with 2 trials as a collaborator, "B. Braun Melsungen AG" with 1 trials as a collaborator and "University of Copenhagen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Dept. of Intensive Care, Tampere University Hospital" are "Septic Shock" (2 trials), "Alcohol Use Disorder" (1 trials), "Continuous Sedation in Initially Sedated Adults in ICU" (1 trials), "Critically Ill" (1 trials) and "Gastrointestinal Bleeding" (1 trials). Many other conditions were trialed in "Dept. of Intensive Care, Tampere University Hospital" in a lesser frequency.

Most popular intervention types in "Dept. of Intensive Care, Tampere University Hospital" are "Drug" (3 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "6% Hydroxyethyl starch 130/0.4" (1 trials), "Brief intervention" (1 trials), "Dexmedetomidine" (1 trials), "Measurement of rectal lactic acid." (1 trials) and "Midazolam" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dept. of Intensive Care, Tampere University Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Dept. of Intensive Care, Tampere University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dept. of Intensive Care, Tampere University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dept. of Intensive Care, Tampere University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".